کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5698885 | 1410384 | 2013 | 25 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: AÂ Systematic Review
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
تومور شناسی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: AÂ Systematic Review Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: AÂ Systematic Review](/preview/png/5698885.png)
چکیده انگلیسی
Docetaxel-based chemotherapy remains the standard of care in men with mCRPC who are candidates for palliative systemic therapy. Promising results are emerging with sipuleucel-T and abiraterone in the pre-docetaxel setting and cabazitaxel, abiraterone and enzalutamide in patients who progress on or after docetaxel. Further research to determine the optimal choice, sequence or even the combination of these agents is necessary.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Oncology - Volume 25, Issue 7, July 2013, Pages 406-430
Journal: Clinical Oncology - Volume 25, Issue 7, July 2013, Pages 406-430
نویسندگان
D.A. Loblaw, C. Walker-Dilks, E. Winquist, S.J. Hotte, Genitourinary Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care Genitourinary Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care,